tiprankstipranks
Trending News
More News >
Memphasys Ltd (AU:MEM)
ASX:MEM
Advertisement

Memphasys Ltd (MEM) Price & Analysis

Compare
7 Followers

MEM Stock Chart & Stats


Memphasys Ltd News

MEM FAQ

What was Memphasys Ltd’s price range in the past 12 months?
Memphasys Ltd lowest share price was <AU$0.01 and its highest was AU$0.01 in the past 12 months.
    What is Memphasys Ltd’s market cap?
    Memphasys Ltd’s market cap is AU$5.95M.
      When is Memphasys Ltd’s upcoming earnings report date?
      Memphasys Ltd’s upcoming earnings report date is Feb 20, 2026 which is in 175 days.
        How were Memphasys Ltd’s earnings last quarter?
        Currently, no data Available
        Is Memphasys Ltd overvalued?
        According to Wall Street analysts Memphasys Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Memphasys Ltd pay dividends?
          Memphasys Ltd does not currently pay dividends.
          What is Memphasys Ltd’s EPS estimate?
          Memphasys Ltd’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Memphasys Ltd have?
          Memphasys Ltd has 1,983,598,100 shares outstanding.
            What happened to Memphasys Ltd’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Memphasys Ltd?
            Currently, no hedge funds are holding shares in AU:MEM

            Memphasys Ltd Stock Smart Score

            4
            Neutral
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10

            Fundamentals

            Return on Equity
            -80.47%
            Trailing 12-Months
            Asset Growth
            -16.41%
            Trailing 12-Months

            Company Description

            Memphasys Ltd

            Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. It primarily develops Felix, a novel automated device for quickly and gently separating high quality sperm from a raw semen sample for use in human IVF procedures. In addition, the company's product pipeline include ROSA, a rapid oxidative stress assay; Samson Device, rapid equine pregnancy prediction assay; SemPort, a central lab human semen analysis from distantly located donors; and AI-Port. An ambient temperature semen transport device used for animal artificial insemination. Memphasys Limited was formerly known as NuSep Holdings Limited and changed its name to Memphasys Limited in July 2016. The company was incorporated in 2006 and is based in Homebush, Australia.

            Memphasys Ltd (MEM) Earnings & Revenues

            Similar Stocks
            Company
            Price & Change
            Follow
            Living Cell Technologies
            Regeneus Ltd.
            Avecho Biotechnology Limited
            AdAlta Ltd.
            Chimeric Therapeutics Ltd.
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis